Show
Sort by
-
Complementarity of single-nucleus and single-cell RNA sequencing to study the transcriptional heterogeneity of neuroblastoma tumors
-
Complementarity of single-nucleus and single-cell RNA sequencing to study the transcriptional heterogeneity of neuroblastoma tumors
-
- Journal Article
- A1
- open access
RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
-
SOX11 as guardian of epigenetic plasticity in neuroblastoma
-
Recurrent chromosomal imbalances provide selective advantage to human embryonic stem cells under enhanced replicative stress conditions
-
- Journal Article
- A1
- open access
The ETS transcription factor ETV5 is a target of activated ALK in neuroblastoma contributing to increased tumour aggressiveness
-
SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma
-
SOX11 as mediator of the adrenergic cell state in NB
-
SOX11 is a key epigenetic regulator in the adrenergic MYCN amplified neuroblastoma
-
Exploring the contribution of gene dosage effects of 17q gain genes on hESC and neuroblastoma proliferation
-
ALK positively regulates MYCN activity through repression of HBP1 expression
-
17q gain provides proliferative advantage to human embryonic stem cells under conditions of replicative stress
-
17q gain provides proliferative advantage to human embryonic stem cells under replicative stress
-
- Conference Paper
- C3
- open access
Exploring the contribution of gene dosage effects of 17q gain on ESC and neuroblastoma proliferation
-
Exploring the contribution of gene dosage effects of 17Q gain on ESC and neuroblastoma proliferation
-
- Conference Paper
- C3
- open access
Exploring the contribution of gene dosage effects of 17q gain on ESC and neuroblastoma proliferation
-
Exploring the contribution of gene dosage effects of 17q gain genes on hESC and neuroblastoma proliferation
-
The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma
-
The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma
-
The ETV5 oncogene is a target of activated ALK signaling in neuroblastoma
-
ETV5 functionally connects ALK and CXCR4 signaling in neuroblastoma
-
ETV5 functionally connect ALK and CXCR4 signaling in neuroblastoma
-
Dual targeting of ALK and RET: establishing a novel basis for the treatment of neuroblastoma
-
Dual targeting of ALK and RET: establishing a novel basis for the treatment of neuroblastoma
-
Sensing mutant ALK: Capicua and ETV5 as executors of aberrant ALK-driven MAPK signaling
-
ETV5 functionally connect ALK and RET signaling in neuroblastoma